The protein produced by the breast cancer susceptibility gene BRCA2 has been purified and used to study its role in DNA repair.
The research by two teams of scientists at the University of California, Davis, could pave way for understanding, diagnosing and perhaps treating familial breast cancer.
Breast Cancer during Pregnancy
Management of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus.
Advertisement
Stephen Kowalczykowski's group has purified the protein from human cells while another group led by Professor Wolf-Dietrich Heyer used genetic engineering techniques to manufacture the human protein in yeast.
BRCA2 protein acts as a mediator, helping another protein, RAD51, to associate with a single strand of DNA and stimulating its activity.
The RAD51/DNA complex then looks for the matching strand of DNA from the other chromosome to make an exact repair, but if the repair system doesn't work, the cell resorts to other, more error-prone methods.
![Women and Cancer]( "Women and Cancer")
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
If that damage is not repaired, errors start to accumulate, Kowalczykowski said. Those errors can eventually lead to cancer.
One application of the purified protein would be to make antibodies to BRCA2 that could be used in test kits as a supplement to existing genetic tests, Kowalczykowski said.
The other would be to use the system to screen for drugs that activate or inhibit the interaction between BRCA2, RAD51 and DNA. It can also be used to study how different mutations affect the gene's function.
"We're just starting to scratch the surface and understand more of the mechanisms and interaction with other factors," Nature quoted Kowalczykowski as saying.
The results are published online in the journals Nature, and Nature Structural and Molecular Biology.
Source: ANI
The RAD51/DNA complex then looks for the matching strand of DNA from the other chromosome to make an exact repair, but if the repair system doesn't work, the cell resorts to other, more error-prone methods.
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Advertisement
If that damage is not repaired, errors start to accumulate, Kowalczykowski said. Those errors can eventually lead to cancer.
One application of the purified protein would be to make antibodies to BRCA2 that could be used in test kits as a supplement to existing genetic tests, Kowalczykowski said.
The other would be to use the system to screen for drugs that activate or inhibit the interaction between BRCA2, RAD51 and DNA. It can also be used to study how different mutations affect the gene's function.
"We're just starting to scratch the surface and understand more of the mechanisms and interaction with other factors," Nature quoted Kowalczykowski as saying.
The results are published online in the journals Nature, and Nature Structural and Molecular Biology.
Source: ANI
Breast Lumps
Most breast lumps are caused by hormonal changes in a woman and may not be cancerous. Common causes of breast lumps include fibroadenosis, breast cancer, breast cyst.
Advertisement
 Breast Lumps-ScreeningBreast lumps must never be neglected but instead be subjected to medical examination to rule out cancer. | Advertisement
|
Advertisement
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable